Ebit mabadiliko
Abbvie ABBV:US $ 4071M 760M
Alcon AG ALC:SW 372M 348M
Amgen AMGN:US $ 2008M 445M
AstraZeneca AZN:LN 605M 823M
Bayer BAYN:GR 2.18B 1.37B
Biogen BIIB:US $ -166.3M 1345M
Bristol Myers Squibb BMY:US $ 1150M 809M
Eli Lilly And LLY:US $ 2328.3M 948.6M
Fresenius FRE:GR 1.25B 135M
Fresenius Medical Care FME:GR 612M 7.63M
Galapagos GLPG:NA -15478000 16.88M
Genmab GEN:DC 887M 29M
Gilead Sciences GILD:US $ 2651M 650M
GlaxoSmithKline GSK:LN 1.62B 850M
GRIFOLS GRF:SM 248.43M 20.24M
H. Lundbeck A/S LUN:DC 70.6M 13.4M
Johnson & Johnson JNJ:US $ 4542M 1659M
Merck MRK:GR 1.25B 602M
Merk MRK:US $ 283M 3527M
Novartis NVS:US 2.65B 673M
Novartis NOVN:VX 2.65B 673M
Orion ORNBV:FH 34.2M 30.9M
Pfizer PFE:US $ 1152M 1309M
Philips PHIA:NA 1.06B 353M
Recordati REC:IM 103.75M 11.28M
Regeneron Pharmaceuticals REGN:US $ 1167M 113.9M



Novartis - Sasa, maadili, data ya kihistoria, utabiri, takwimu, chati na kalenda ya kiuchumi - Mar 2021.